Effects of Crystalloid and Colloid Preload

合集下载

预充不同液体对腰硬联合麻醉下急诊剖宫产孕妇血流动力学的影响

预充不同液体对腰硬联合麻醉下急诊剖宫产孕妇血流动力学的影响

2012年12月第19卷第12期收稿日期:2012-09-24作者简介:何颖宜(1980-),女,广东广州人,医师,临床医学本科学历,学士学位,主要研究方向为临床麻醉学和疼痛学。

*通讯作者:程平瑞,E-mail:cpr125@163.com·论著·(临床研究)腰硬联合麻醉起效快、镇痛效果好,是剖宫产手术理想的麻醉方法,其最常见的并发症是低血压[1]。

扩充血容量是预防术中出现严重低血压的方法之一,而胶体液其扩容能力强,是扩容的首选。

但对于急诊剖宫产病人,由于术前准备时间迫切,手术进行时间短,麻醉前预充不同液体对孕妇的血流动力学影响效果报道不一[2]。

本文旨在探讨麻醉前预充胶体和晶体液对腰硬麻下急诊剖宫产术中母体血流动力学的影响,对液体应用提供参考。

1资料与方法1.1一般资料本研究经广州市番禺区中心医院伦理委员会批准,签署知情同意书。

选取本院产科进行的足月单胎急诊剖宫产术100例,年龄20~35岁,体重50~80k g,身高155~170cm,ASAⅠ~Ⅱ级,排除合并严重心、脑、肾、肺疾患,无高血压、糖尿病史,无羟乙基淀粉过敏史,无椎管内麻醉禁忌症,排除合并产科复杂情况,如巨大胎、胎盘早剥、前置胎盘、子宫肌瘤等。

麻醉平面超过T4或低于T10者不纳入研究中。

100例产妇随机分为两组,Ⅰ组为乳酸钠林格液组(晶体组),Ⅱ组为6%羟乙基淀粉(130/0.4)氯化钠注射液(万汶)组(胶体组)。

两组产妇年龄、身高、体重、ASA分级、妊娠周数等差异无统计学意义,具有可比性。

预充不同液体对腰硬联合麻醉下急诊剖宫产孕妇血流动力学的影响何颖宜,程平瑞*,梁健华,陈少妤,林丽田,杨琳(广州市番禺区中心医院麻醉科,广东广州511400)【摘要】目的探讨麻醉前预充胶体液和晶体液对腰硬联合麻醉下急诊剖宫产术孕妇血流动力学的影响。

方法100例足月妊娠孕妇(ASAⅠ~Ⅱ级)随机分为晶体组(Ⅰ组)和胶体组(Ⅱ组),各50例。

美国重症医学FCCM的基础教程 创伤和烧伤的处理

美国重症医学FCCM的基础教程 创伤和烧伤的处理
solution • Follow with packed red blood cells after 2–3 L
of crystalloid • Control external hemorrhage by compression • Monitoring – data flow sheet, vital signs, ECG,
Rule of Nines
TRA 18
®
Resuscitation – Burn Shock
• Primary fluid loss from wound • Secondary nonburn edema • Principles
– Avoid excess fluid resuscitation but maintain organ perfusion
• Radiograph review – Cervical spine – complete survey – Chest – mediastinal evaluation; tubes/catheters – Pelvis – major fractures – Cystogram/urethrogram – Skeletal exam
TRA 20
®
Burn Wound Care
• Gently wash and cover prior to transport • Remove rings, bracelets • Burn dressings controversial before transfer • Consultation for specific wound care
15–30
30–40
&morrhagic Shock
• Chest – hemothorax; drain and monitor • Abdominal

剖宫产术中恶心呕吐的原因分析及护理对策

剖宫产术中恶心呕吐的原因分析及护理对策

剖宫产术中恶心呕吐的原因分析及护理对策摘要:造成剖宫产术中恶心呕吐的原因较为复杂,而且往往是多种因素共同作用的结果,其中包括低血压、妊娠期间消化系统的改变、恐惧焦虑等不良心理状态、疼痛、手术牵拉等,对这些原因进行分析,并总结出相应的护理对策,如开放有效的静脉通路,改变产妇体位以预防仰卧位综合症,心理舒适护理,减少或停止手术探查或操作,吸氧以缓解缺氧对脑组织的刺激,加强呕吐病人的护理,给予药物治疗和指压穴位法治疗;根据不同的原因选择合适的治疗方法,从而有效地预防术中恶心呕吐的发生,保证手术的顺利进行。

关键词:剖宫产术中恶心呕吐原因分析护理对策近几年我国剖宫产率日益增多,一般为30%左右[1],虽然手术难度小,手术所用时间短,但是有很多产妇由于各种原因仍然会出现恶心呕吐现象,恶心与呕吐不仅给术者增添痛苦,而且可直接影响到术中呼吸道的管理及术后的恢复,严重者可因反流误吸发生吸人性肺炎、窒息、甚至死亡,所以作好产妇的呕吐护理至关重要。

我院2006年1月到2007年1月,共做剖宫产手术856例,术中出现呕吐情况99例,我们针对其相关因素作了回顾性分析,并总结出相应的护理措施,现报告如下:1.资料与方法:2006年1月到2007年1月共有剖宫产手术856 例,年龄为21-41岁,平均年龄为26±0.25岁。

术前妊高征患者59例,二次手术53 例,饱食者137例。

所有产妇均采用蛛网膜下腔阻滞麻醉,其中有617例患者采取硬腰联合麻醉,159例采取硬膜外麻醉方式,80例采取腰麻,共发生呕吐现象者99例,发生率为11.5%。

发生在麻醉完成平卧时26例,进入腹腔后66例,关腹时7例。

2.原因分析:2.1低血压呕吐现象的发生与低血压密切相关,血压下降后脑组织的血流灌注量必然减少,脑组织的能量储备很少,容易引起缺血缺氧,并刺激呕吐中枢引起恶心呕吐。

2.1.1 仰卧位低血压综合征(SHS) 经过放射学检查发现,在平卧位时约有90%的临产妇的下腔静脉被子宫所压,甚至完全阻塞[1],使回心血量减少,表现为呼吸困难,血压下降,脉搏快而弱,并出现头晕、恶心、呕吐、出汗等症状,继而使胎盘血流量减少,胎儿宫内窘迫,不及时处理可危及生命[2]。

剖宫产脊麻低血压的防治进展

剖宫产脊麻低血压的防治进展

醉后产妇的低血压发生率(80%)明显高于硬膜外麻醉
(45%)[11。母亲低血压可能导致胎儿窘迫和母亲不适。近年 对剖宫产脊麻低血压的防治策略研究形成了一些新的有争 议的观点,而临床上防治脊麻低血压的方法也多样而不统 一,液体预负荷和麻黄碱使用仍很普遍[2】。本文对近年有关 割宫产脊麻低血压防治策略的研究进展做了一个综述。 1脊麻低血压机制和危害 脊麻低血压的病理生理学机制已被很好的描述。低血 压通常被限定为收缩压低于100 mmHg或者低于基础值的 20%以上,其发生率和严重程度取决于阻滞平面的高低、产 妇的体位以及是否采取了预防措施来避免这种低血压。其 原因主要是由于脊麻对交感神经纤维的阻滞使阻滞平面以 下的血管扩张,静脉淤血,因而减少了心输出量.造成血压 下降。交感神经阻滞后迷走神经的相对紧张和仰卧位低血 压综合征可使产妇的血流动力学紊乱更加明显[31。背麻时母 亲低血压的发生率在大多数实验超过了50%[“】.远高于全 身麻醉和硬膜外麻醉。低血压会引起母亲恶心呕吐。治疗不 当还可能导致医源性肺水肿和严重的母亲高血压。此外。产 妇还可能由于低血压不能很好的合作而使手术变得复杂。 胎儿也会受到低血压的影响。由于子宫胎盘循环缺乏 自身调节机制,灌注完全依赖于合适的母体血压的维持。而 胎儿的正常氧化代谢需要良好的胎盘灌注。母体血压降低 会造成胎儿循环障碍和缺氧。因此。如果低血压严重或者持 续较久可能会使胎儿出现酸中毒。在一项Mem分析中. Reynolds等[o]确认相比于硬膜外麻醉和全身麻醉.脊麻造成 了更多的新生儿酸中毒。因此。探寻一种能够有效的防治割 宫产脊麻低血压并发症的方法一直为产科麻醉临床研究所 关注。 2脊麻低血压防治策略 5~10年前的产科麻醉学教科书建议在手术时采用给 产妇晶体预负荷和保持使子宫左侧移位的体位来防止低血 压。如果发生低血压,则麻黄碱是应该选择的治疗药物.因 为麻黄碱对胎儿是安全的,不会造成胎儿酸中毒。然而.近 几年这些观念受到了挑战。

感染性休克指南详解

感染性休克指南详解

• administration of broad spectrum antibiotic therapy within1 hr of diagnosis of septic shock (1B) and severe sepsis without septic shock (1D) • 感染性休克和严重脓毒血症而无休克的诊断后1小时内实 用广谱抗生素 • reassessment of antibiotic therapy with microbiology and clinical data to narrow coverage, when appropriate(1C); • 选择合适的时机根据微生物和临床资料重新评估抗生素疗 法以缩小抗菌谱 • a usual 7–10 days of antibiotic therapy guided by clinical response (1D) • 根据临床反应使用常规7-10天抗生素疗法
Diagnosis
• application of at least a minimal amount of positive endexpiratory pressure in acute lung injury (1C) • ALI使用至少小量呼气末正压 • head of bed elevation in mechanically ventilated patients unless contraindicated (1B) • 除非禁忌,机械通气患者的床头可以抬高 • avoiding routine use of pulmonary artery catheters in ALI/ARDS (1A) • ALI/ARDS避免常规使用肺动脉导管 • to decrease days of mechanical ventilation and ICU length of stay, a conservative fluid strategy for patients with established ALI/ARDS who are not in shock (1C) • 为了减少呼吸机使用天数和ICU住院天数,对于确诊ALI/ARDS而没 有休克的患者,要采用保守的补液目标

人血白蛋白临床不合理应用及改进措施

人血白蛋白临床不合理应用及改进措施

人血白蛋白临床不合理应用及改进措施常花蕾;史涛【摘要】人血白蛋白是从健康人的血液中提取制成,主要用于治疗因烧伤、创伤引起的休克,低蛋白血症,新生儿高胆红素血症,脑水肿及损伤引起的颅压升高,肝硬化及肾病引起的水肿等。

临床上,人血白蛋白存在一些不合理使用的现象,如作为营养品、提高免疫力、体液治疗等。

本文通过查阅国内外相关文献,结合临床实践,探讨人血白蛋白不合理应用现象并提出相应的改进措施,如明确其临床应用指征、加强临床应用管理、开展循证医学评价、加强理论知识培训等,以期为临床合理用药提供参考。

%Human serum albumin is extracted and manufactured from the blood of healthy people, which had been mainly used in conditions including shock caused by burn and trauma, hypoalbuminemia, neonate hyperbilirubinemia, intracranial hypertension caused by brain edema and injury, edema caused by liver cirrhosis and nephropathy, etc. Serious irrational use of human serum albumin, such as regarding it as nutriment, used for enhancing immunity, lfuid therapy and so on can be found in clinic. Combined with clinical investigation, the common phenomenons of irrational use of human serum albumin in clinic were discussed through reviewing literatures in recent years at home and abroad, the corresponding improvement measures were given, including distinguishing indication of clinical application, strengthening the management of clinical use, carrying out evaluation of evidence-based medicine, enforcing theory training and so on, so as to provide references for clinical rational use of human serum albumin.【期刊名称】《中国药物应用与监测》【年(卷),期】2014(000)001【总页数】3页(P52-54)【关键词】人血白蛋白;不合理应用;改进措施【作者】常花蕾;史涛【作者单位】解放军第一七四医院药剂科,福建厦门 361003;解放军第一七四医院药剂科,福建厦门 361003【正文语种】中文【中图分类】R97人血白蛋白(human serum albumin,HSA)于1940年应用于临床[1],其制剂均经过严格加工处理,因有独特的药理作用,临床适应证极为广泛,但其价格昂贵、使用方法复杂且有副作用,使临床很难准确把握适应证,存在一些滥用和误用的现象。

透析发展史

透析发展史

• •
• •
Father of Dialysis-1943

1943 第一个现代转鼓式人工肾 1943 首次治疗血透患者,但未存活 1945年9月 Kolff治疗1例急性胆囊炎伴
急性肾衰竭的昏迷患者,经过透析11.5小时 后,神志改善,1周后开始利尿,患者康复 出院,这是历史上第一例由人工肾成功
1920-1925年 Love/Necheles/Haas分别利用腹膜加工制成透析膜,对切除双 侧肾脏的狗进行透析,使尿毒症症状改善 有了可利用的半透膜后, 科学家们开始着手制造透析机

首次人体试验-1926

1926年 第一例轻尿毒症患者做透析治疗,但未取得治疗效果,但是人 体的实验为今后的发展。 1927年 Hass又对两例患者进行透析治疗,取得了一定的治疗效果


1981年 碳酸氢盐开始广泛使用
1982年 美国医疗仪器促进会公布透析水质标准 1988年 可调钠,高流量的透析机出现 1993年 肾脏替代疗法 1995年 美国肾脏基金会提出的透析预后及生活质量纲要(NKF-DOQI) 1996年 连续性肾脏替代疗法
到目前,全世界约有100多万尿毒症患者在接受透 析治疗,存活时间长达30多年。 血液透析60年代进入我国,发展速度极慢,70年 代中期肾脏替代治疗在我国才蓬勃开展。
venous drip chamber arterial blood pump lines
发 展 目 标
70年代 减少并发症
arterial drip chamber venous line clamp
80年代 提高生活质量
血液净化的临床应用
在实际临床中,相关的疾病都可能与血液净化有关。心功能衰竭、代 谢性紊乱、酸碱失衡、免疫系统疾病、药物中毒、传染性疾病、肝脏的 损害、外伤、神经系统疾病等等------

人血白蛋白处方点评标准

人血白蛋白处方点评标准

人血白蛋白处方点评标准(讨论稿)为规范人血白蛋白的临床使用,降低药品费用,改善人血白蛋白短缺现状,促进人血白蛋白的合理使用,开展人血白蛋白临床应用相关处方或医嘱点评工作具有重要意义。

为此,药剂科综合参考《处方管理办法》(卫生部令第53号)、《医院处方点评管理规范(试行)》(卫医管发〔2010〕28号)、美国大学医院联合会《人血白蛋白、非蛋白胶体及晶体溶液使用指南》、北京地区《血液制品处方点评指南》以及人血白蛋白说明书、相关循证医学依据等,结合我院临床实际,制定我院人血白蛋白临床使用评价标准初稿。

【点评标准】1.适应证不适宜;2.用法、用量不适宜;3.遴选的药品不适宜;4.药品剂型或给药途径不适宜;5.联合用药不适宜;6.重复给药;7.有配伍禁忌或者不良相互作用;8.其它用药不适宜情况;【点评细则】1.适应证不适宜:“诊断”栏未注有符合以下情况一项或一项以上适应证者判定为适应证不适宜。

?严重失血、创伤与烧伤等引起的休克;纠正人血白蛋白作为补充血容量的首选药物的误区。

《美国医院联合会人血白蛋白、非蛋白胶体及晶体溶液使用指南》(简称UHC,下同)[1]中提到:对于出血性休克,晶体溶液可作为首选药物用于扩张血容量,成人患者输入4L晶体液后2h无效,可考虑非蛋白胶体液,当对非蛋白胶体液有禁忌时才考虑使用5%白蛋白。

目前的循证医学证据表明在外科病人中,对于病死率、并发症发生率的结局指标,不同种类的胶体液并未显示出明显差异。

?脑水肿及大脑损伤所致的颅压升高;人血白蛋白可提高血浆胶体渗透压,将脑组织的水分转移到血管内而减轻脑水肿,降低颅内压。

对于蛛网膜下腔出血、缺血性中风与头部创伤引起的血管痉挛,应首选晶体溶液维持脑灌注压。

如果存在脑水肿的危险,应使用高浓度白蛋白(25%)胶体液维持脑灌注压【1】。

?新生儿高胆红素血症;新生儿高胆红素血症为人血白蛋白的适应症,白蛋白能与血中胆红素结合,阻止胆红素通过血脑屏障,促进胆红素排泄。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

ⅥCLINICAL INVESTIGATIONSAnesthesiology1999;91:1571–6©1999American Society of Anesthesiologists,Inc.Lippincott Williams&Wilkins,Inc.Effects of Crystalloid and Colloid Preload on Blood Volume in the Parturient Undergoing Spinal Anesthesia for Elective Cesarean SectionHiroshi Ueyama,M.D.,*Yan-Ling He,Ph.D.,†Hironobu Tanigami,M.D.,*Takashi Mashimo,M.D.,‡Ikuto Yoshiya,M.D.§Background:The role of crystalloid preloading to prevent hypotension associated with spinal anesthesia in parturients during cesarean section has been challenged.Direct measure-ment of blood volume should provide insight regarding the volume-expanding effects.The aim of the current study was to clarify the effects of volume preload with either crystalloid or colloid solution on the changes in blood volume of parturients undergoing spinal anesthesia for cesarean section. Methods:Thirty-six healthy parturients scheduled for elective cesarean section during spinal anesthesia were allocated ran-domly to one of three groups receiving1.5l lactated Ringer’s solution(LR;n؍12),0.5l hydroxyethylstarch solution,6%(0.5 l HES;n؍12),and1.0l hydroxyethylstarch solution,6%(1.0l HES;n؍12),respectively.Blood volume and cardiac output were measured before and after volume preloading with indo-cyanine green(ICG),and the indocyanine green blood concen-trations were monitored by noninvasive pulse spectrophotom-etry.Results:After volume preload,the blood volume significantly increased in all three groups(P<0.01).The volume of infused solution remaining in the vascular space in the LR,0.5-l HES, and1.0-l HES groups were0.43؎0.20l,0.54؎0.14l,and1.03؎0.21l,respectively,corresponding to28%of lactated Ringer’ssolution and100%of hydroxyethylstarch solution infused.Sig-nificant increases in cardiac output were observed in the0.5-land1.0-l HES groups(P<0.01).A significant correlation be-tween the percentage increase in blood volume and that ofcardiac output was observed by volume preloading(r2؍0.838; P<0.001).The incidence of hypotension was75%for the LRgroup,58%for the0.5-l HES group,and17%for the1.0-l HESgroup,respectively.Conclusions:The incidence of hypotension developed in the1.0-l HES group was significantly lower than that in the LR and0.5-l HES groups,showing that greater volume expansion resultsin less hypotension.This result indicates that the augmentation ofblood volume with preloading,regardless of thefluid used,mustbe large enough to result in a significant increase in cardiac outputfor effective prevention of hypotension.(Key words:Cardiacoutput;hydroxyethylstarch solution;indocyanine green;lac-tated Ringer’s solution;pulse spectrophotometry.)ACUTE administration of crystalloid solution to parturi-ents undergoing spinal anesthesia for cesarean sectionhas been recommended to reduce the incidence andseverity of hypotension before the induction of spinalanesthesia.1–3However,several investigations have re-cently shown that increasing the amount of crystalloiddoes not eliminate the incidence of hypotension orephedrine requirements after spinal anesthesia.4–7Col-loid solutions,such as5%albumin,6%hydroxyethyl-starch(HES),and gelatin,are also used for preventingthe hypotension associated with spinal anesthesia.8,9Preloading the circulation with crystalloids or colloids isaimed at the volume expansion that alleviates the vaso-dilation induced by spinal anesthesia.Most of the previ-ous investigations of the effects of preloading with avariety offluids have focused on the incidence andseverity of hypotension and some vital signs,such assystolic blood pressure(SBP)and heart rate.These vari-ables do not directly reflect the volume expansion effectbecause they are not only influenced by the volumestatus,but also by many other factors,such as cardiacfunction,vascular tone,and aortocaval compres-This article is accompanied by an Editorial View.Please see:Rout C,Rocke DA:Spinal hypotension associated with cesar-ean section:Will preload ever work?A NESTHESIOLOGY1999;91:1565–7.᭜*Assistant Professor,Department of Anesthesiology.†Research Fellow,Department of Anesthesiology.‡Professor and Chairman,Department of Anesthesiology.§Professor and Chairman,Department of General Medicine.Received from the Department of Anesthesiology,Osaka UniversityMedical School,Osaka,Japan.Submitted for publication September29,1998.Accepted for publication June29,1999.Supported in part byMonbusho Grant-in-Aid from the Japan Society for the Promotion ofScience,Tokyo,Japan.Presented in part at the annual meeting of theAmerican Society of Anesthesiologists,New Orleans,Louisiana,Octo-ber21–23,1996.Address reprint requests to Dr.Ueyama:Department of Anesthesiology,Osaka University Medical School,Yamadaoka2-2,Suita,Osaka565-0871,Japan.Address electronic mail to:ueyama@hp-op.med.osaka-u.ac.jp1571sion.7,10–12Direct measurement of blood volume(BV)should provide insight regarding the volume-expandingeffects of crystalloid or colloid solutions.Until now,noinvestigation of the changes in BV after crystalloid orcolloid preloading has been performed because BV mea-surement is a time-consuming and complicated proce-dure that necessitates blood sampling and indicator con-centration measurement at the laboratory level.Asophisticated system that can noninvasively measure theblood concentration of indocyanine green(ICG)usingpulse spectrophotometry,based on the same principleas oximetry,recently was developed.The accuracy andreproducibility of measuring BV and cardiac output(CO)using this system have been investigated.13–15The cur-rent study was designed to clarify the effects of volumepreload,with either crystalloid or colloid solutions,onthe changes both in BV and CO of parturients undergo-ing spinal anesthesia for cesarean section.Materials and MethodsParturientsThis study was approved by the Institutional ReviewBoard,Osaka University Medical School,Osaka,Japan,and informed consent was obtained from36healthy,full-term parturients scheduled for elective cesarean sec-tion during spinal anesthesia.Patients with abruptio pla-centa,placenta previa,multiple gestation,and pre-eclampsia,or who were receiving ritodrine or other ␤-tocolytic agents were excluded from the current study.Only an H2blocker(ranitidine hydrochloride,100mg)was administered orally the night before,and noother medicine was administered.Parturients were allo-cated randomly to one of three groups:the lactatedRinger’s solution(LR)group received1.5l LR solution(nϭ12),the0.5-l hydroxyethylstarch solution(HES)group received0.5l hydroxyethylstarch solution,6%(saline HES;Kyorin Pharmaceutical Inc.,Tokyo,Japan),with an average molecular weight of70,000d and asubstitution ratio of0.55(nϭ12),and the1.0-l HESgroup received1.0l of the same HES solution(nϭ12),respectively.The LR and the HES solutions each wereinfused over a30-min period before the induction ofspinal anesthesia.Study DesignAn intravenous catheter was inserted into a peripheralvein and5%glucose solution was infused at a rate of100ml/h.The BV and CO measurements were performed with the patient in the right lateral position to avoid aortocaval compression byfixing the probe to the left indexfinger.Thefirst measurement of BV,which was regarded as the baseline value,was performed in the obstetric ward before the volume preload,approxi-mately1h before the induction of spinal anesthesia. After the volume loading,BV was again measured using the same device.Spinal anesthesia was undertaken dur-ing the infusion of an additional500ml LR solution in all groups.Lumbar punctures were performed by using a 25-gauge spinal needle at the L3–L4intervertebral space with patients in the right lateral position.Spinal anesthe-sia was achieved by administrating8.0mg tetracaine hydrochloride and100␮g preservative-free morphine hydrochloride in10%dextrose.After spinal block,parturients were placed in the su-pine position with a wedge placed under the right hip to obtain a15°left uterine displacement.Maternal blood pressure and heart rate were monitored at1-min inter-vals from the induction of spinal anesthesia to delivery, and every5min thereafter(M2360A;Hewlett Packard, Andover,MA).Hypotension was defined as a decrease in SBP to less than100mmHg and less than80%of the baseline value.Hypotension was treated with10mg ephedrine at2-min intervals.Oxytocin was administered to all parturients at a rate of2to3U/h after delivery. Methyl ergonovine or prostaglandin F2␣,or both,were administered when necessary to prevent the parturients from postpartum hemorrhage.Measurement of Blood VolumeBlood volume was estimated using ICG as an indicator. Ten milligrams of ICG was administered in an intrave-nous bolus dose within1s via a cannula placed in the peripheral vein,and the blood ICG concentration was monitored via pulse spectrophotometry using a probe fixed on the patient’s left indexfinger.The measurement of blood ICG concentrations by pulse spectrophotome-try operates by the same principle as the monitoring of oxygen saturation measured by pulse oximetry(Sp O2).It is designed using the principles of light absorbency and pulse detection,in which endogenous hemoglobin is used as the reference material.16The integrated pulse spectrophotometry monitoring system is composed of a finger probe,a monitoring device,and a computer for recording and printing the results(DDG1001;Nihon Kohden Inc.,Tokyo,Japan).Before injection of ICG, approximately0.5ml of blood was drawn and placed in a heparinized syringe to measure the hemoglobin con-centration(ABL601;Radiometer,Copenhagen,Den-1572UEYAMA ET AL.mark),which is necessary for calculating ICG blood concentration.Blood ICG concentration was measured immediately after the administration of ICG.The BV and CO were estimated based on the ICG blood concentra-tion time courses as follows:BV ϭDose C MTT(1)where C MTT is the blood concentration of ICG at the mean transit time (MTT)calculated from the first dilu-tion curve.CO ϭDose first(2)where AUC first is the area under the first dilution curve calculated based on the trapezoidal rule.Statistical AnalysisData are represented as the mean ϮSD.The differ-ences for age,weight ,height,and gestational age amongthe three groups were studied using the Kruskal-Wallis rank test.Two-way analysis of variance and the Newman-Keuls test were used for the comparisons of BV,CO,SBP,and hemoglobin concentration among the three groups.For each group,values before and after volume preload were compared using a paired t test,and Bon-ferroni correction was conducted to evaluate the P value.The incidence of spinal hypotension was com-pared using the chi-square test.The coefficient of corre-lation between percent change in CO and in BV were analyzed by using polynomial regression.A value of P Ͻ0.05was considered statistically significant.ResultsDetails of the maternal characteristics and various he-modynamic values are summarized in table 1.There were no significant differences among the three groups with regard to age,weight,height,and gestational age.In addition,there also were no differences observed inTable 1.Maternal Characteristics and Hemodynamics in Response to Volume Preload with either LR or HESLR0.5L HES1.0L HESN121212Age (yr)32Ϯ0.330Ϯ5.332Ϯ3.6Weight (kg)60.6Ϯ3.761.3Ϯ5.362.4Ϯ7.5Height (cm)156Ϯ6.4157Ϯ5.8160Ϯ4.5Gestational age (wk)39Ϯ0.339Ϯ0.539Ϯ0.3Blood volume (l)Baseline5.33Ϯ0.46 5.28Ϯ0.59 5.30Ϯ0.55After volume preload 5.76Ϯ0.52* 5.82Ϯ0.63*6.33Ϯ0.67*†࿣Cardiac output (l/min)Baseline5.4Ϯ1.0 5.4Ϯ1.0 5.10Ϯ1.0After volume preload6.0Ϯ1.0 6.2Ϯ0.6*7.3Ϯ1.1*†‡Level of anesthesiaT4(2–6)T4(1–5)T4(2–4)Systolic blood pressure (mmHg)Baseline117Ϯ7114Ϯ9116Ϯ7After volume preload119Ϯ7121Ϯ12118Ϯ9Lowest following spinal anesthesia 88Ϯ10*92Ϯ10*102Ϯ10*†‡Incidence of hypotension (%)755817§࿣Heart rate (beats/min)Baseline74Ϯ1173Ϯ772Ϯ8After volume preload80Ϯ978Ϯ878Ϯ11Lowest following spinal anesthesia 78Ϯ1277Ϯ779Ϯ9Hemoglobin concentration (mg/dl)Baseline10.9Ϯ0.711.0Ϯ0.811.0Ϯ0.9After volume preload9.8Ϯ0.8*9.9Ϯ1.0*8.9Ϯ0.7*†‡Values are mean ϮSD.*P Ͻ0.01versus baseline.†P Ͻ0.01versus LR.‡P Ͻ0.01versus 0.5L HES.§P Ͻ0.05versus LR.࿣P Ͻ0.05versus 0.5L HES.HES ϭhydroxyethylstarch;LR ϭlactated Ringer’s.1573EFFECTS OF VOLUME PRELOAD ON BLOOD VOLUMEthe baseline values of BV,CO,SBP,heart rate,and hemoglobin concentration among the three groups.The BV measured with ICG before and after preloading the circulation with LR,0.5l HES,6%,or 1.0l HES,6%,were significantly increased (5.33Ϯ0.46l vs.5.76Ϯ0.52l;5.28Ϯ0.59l vs.5.82Ϯ0.63l;5.30Ϯ0.55l vs.6.33Ϯ0.67l;P Ͻ0.01for all comparisons).The volumes remaining in the vascular space after administration of 1.5l LR,0.5l HES,6%,or 1.0l HES,6%,over 30min were 0.43Ϯ0.20l,0.54Ϯ0.14l,and 1.03Ϯ0.21l,respec-tively,which correspond to 28%of the LR solution and 100%of the HES solution infused.The BV in the 1.0-l HES group after volume preload (6.33Ϯ0.67l)was signifi-cantly greater than that in the LR and 0.5-l HES groups (5.76Ϯ0.52l and 5.82Ϯ0.63l ;P Ͻ0.01).Cardiac output in the 0.5-l and 1.0-l HES groups was significantly increased by volume preloading (table 1;P Ͻ0.01),and the CO for the 1.0-l HES group showed a significantly higher value than that for the LR and 0.5-l HES groups (P Ͻ0.01).The relation between the percent change in BV and that in CO by volume preloading is shown in figure 1.A significant curvilinear correlation was ob-served between the percentage change in BV and that in CO (r 2ϭ0.838;P Ͻ0.001).The mean values of SBP remained unchanged after preloading with the LR solu-tion or either HES solution (table 1).As the lowest values recorded within 10min after spinal anesthesia indicated,the mean values of SBP were decreased significantly by spinal anesthesia in all three groups.Irrespective of thesimilar level of spinal anesthesia for all three groups (table 1),the lowest SBP after spinal anesthesia observed in the 1.0-l HES group (102Ϯ10mmHg)was maintained at a significantly higher level than that of the LR and 0.5-l HES groups (88Ϯ10mmHg and 92Ϯ10mmHg,respectively;P Ͻ0.01).Spinal anesthesia–induced hy-potension was observed in 75%of parturients in the LR group,in 58%of parturients in the 0.5-l HES group,and in 17%of parturients in the 1.0-l HES group.The inci-dence of hypotension was significantly lower in the 1.0-l HES group than in the LR and 0.5-l HES groups (P Ͻ0.05).Heart rate was not influenced by volume preload-ing in all three groups.Hemoglobin concentrations were decreased significantly by volume preload in all three groups (P Ͻ0.01).DiscussionBecause Wollman and Marx 1proposed the importance of fluid infusion to counteract the relative hypovolemia induced by spinal anesthesia,various fluids,including crystalloids and colloids,have been used for preloading before spinal anesthesia for cesarean section.Many stud-ies have been reported 1–9regarding the effects of vol-ume preload,using various fluids,on the incidence and severity of hypotension induced by spinal anesthesia;however,no investigations have been conducted to di-rectly clarify the effects of volume preload on BV be-cause of the difficulty in measuring the BV of parturients.In this study,we directly measured BV and CO at the bedside by administering an intravenous injection of ICG that was monitored noninvasively using the newly de-veloped approach of pulse spectrophotometry.13,16,17Preloading with 1.5l LR solution,which corresponds to approximately 30%of the basal BV before preloading circulation,resulted in only an 8%increase in the BV of parturients.The finding that only 28%of infused LR remained in the vascular space after infusion over 30min is not surprising because crystalloid solution,such as LR,has a short intravascular half-life because of its rapid distribution into the interstitial space.We observed a high incidence of hypotension of 75%for this group,which was comparable to that found in the previous studies by Robson et al.18and Riley et al.19The BV of parturients preloaded with 0.5l HES,6%,increased by 10%,and the incidence of hypotension was 58%,which was not significantly different from the LR group.Al-though 100%of infused 6%HES remained in the vascular space,the volume of 0.5l or the resultant 10%increaseFig.1.The relation between percent change in blood volume and cardiac output after volume preload with 1.5l lactated Ringer’s solution (ࠗ),0.5l hydroxyethylstarch solution,6%(ⅷ),and 1.0l hydroxyethylstarch solution,6%(؋).1574UEYAMA ET AL.in BV were ineffective in preventing the hypotension associated with spinal anesthesia.A20%increase in BV was achieved by preloading the circulation with1.0l HES,6%,and the incidence of hypotension was signifi-cantly decreased to17%,as compared with the LR and 0.5-l HES groups(PϽ0.05).Therefore,a greater in-crease in BV may be necessary to prevent the hypoten-sion associated with spinal anesthesia.Spinal block causes peripheral vasodilation and venous pooling,which may result in maternal hypotension.In-vestigations regarding the effects offluid preloading on maternal hemodynamic factors such as CO and systemic vascular resistance(SVR)would be helpful for discussion of the meaning and usefulness of volume preloading. Park et al.7measured the cardiac index and systemic vascular resistance index in parturients undergoing spi-nal anesthesia for cesarean section using noninvasive thoracic impedance monitoring.They observed a similar and significantly decreased systemic vascular resistance index among groups receiving10,20,or30ml/kg LR and an unchanged cardiac index.Wennberg et al.12 measured cardiac index in parturients preloaded with dextran(15ml/kg)using a similar technique to that of Park and et al.7and observed no significant changes in maternal heart rate and cardiac index until induction of extradural anesthesia.Conversely,Robson et al.18,20 measured the CO using Dopplerflow combined with cross-sectional echocardiography at the aortic valve in parturients undergoing spinal or extradural anesthesia for cesarean section,demonstrating that CO increased after preloading the circulation with1000–2200ml LR solution.Several studies18,20,21have reported the de-creased CO in parturients after spinal or epidural anes-thesia and suggested that the hypotension induced by spinal or epidural anesthesia is associated with a marked decrease in CO.It seems that the effects of crystalloid and colloid preload on CO vary in different studies, depending on the variations influids infused,the pro-phylactic or simultaneous administration of ephedrine, and the approaches of measuring CO.7,12,18In the current study,CO was measured noninvasively with ICG using pulse spectrophotometry.This new method has been shown to have the same degree of accuracy as the conventional thermodilution method for measuring CO.17We observed a significant curvilinear correlation between the percent change in BV and CO by volume preload.The conflicting results reported from many studies of the preventive effects of volume preload based on the incidence and severity of hypotension might be attributed to the insufficient augmentation of BV to result in a significant change in maternal CO because of the variety in the volumes andfluids used.As relative hypovolemia associated with spinal anesthesia reduces CO by lowing venous return,effective volume expansion with crystalloid or colloid will certainly aug-ment the venous return.Volume preloading with either 0.5-l or1.0-l HES,6%,induced significant increases in CO in parturients.Because no significant change was found in heart rate before or after volume preload,the signifi-cant increase in CO after volume preload with6%HES solution can be attributed to the increase in stroke vol-ume.The percentage increases by volume preload rela-tive to the baseline CO in the0.5-l HES and1.0-l HES groups were14%and43%,respectively.Measurement of BV and CO after spinal anesthesia would have provided valuable information regarding the relation between BV and CO and the relation between the incidence of hy-potension and CO.However,this measurement could not be performed.For subsequent measurements(at least a40-min interval is necessary),the period between establishment of spinal anesthesia and the birth of the infant was less than40min.Riley et al.19compared the effectiveness of preloading the circulation with either2l LR or1l LR plus0.5l HES, 6%.They observed spinal hypotension in45%of patients who received HES(0.5l)plus LR(1l)versus85%of those who received LR(2l)only.They concluded that 6%HES plus LR is more effective than LR alone.Al-though Marthu et al.8reported complete prevention of spinal hypotension by preloading the circulation of par-turients with approximately1l albumin,5%;HES,which is cheaper than albumin,seems to be more practical. Our results support the opinion of Riley et al.,19who advocated the routine use of6%HES solution before spinal anesthesia for cesarean section,based on several years of routine use in their obstetric service.In summary,BV was significantly increased by volume preload with1.5l LR or0.5l or1.0l HES,6%,solutions, and the percentage increments relative to the basal BV were8%,10%,and20%,respectively.A significantly lower incidence of hypotension associated with spinal anesthesia in the1.0-l HES group was observed as com-pared with the LR and0.5-l HES groups.The significant correlation between the percent change in BV and CO suggests that the augmentation of BV with volume pre-load must be great enough to result in a significant increase in CO.The authors thank Naoki Kobayashi and Takuo Aoyagi of Nihon Kohden Inc.,Tokyo,Japan,for technical support and Nobuaki Mit-1575EFFECTS OF VOLUME PRELOAD ON BLOOD VOLUMEsuda,M.D.,Tohru Kanzaki,M.D.,and Yuhji Murata,M.D.,from the Department of Obstetric and Gynecology,Osaka University Medical School,Osaka,Japan.References1.Wollman SB,Marx GF:Acute hydration for prevention of hypo-tension of spinal anesthesia in parturients.A NESTHESIOLOGY1968;29: 374–802.Marx GF,Cosmi EV,Wollman SB:Biochemical status and clinical condition of mother and infant at cesarean section.Anesth Analg1969; 48:986–943.Clark RB,Thompson DS,Thompson CH:Prevention of spinal hypotension associated with cesarean section.A NESTHESIOLOGY1976; 45:670–44.Rout CC,Akoojee SS,Rocke DA,Gouws E:Rapid administration of crystalloid preload does not decrease the incidence of hypotension after spinal anaesthesia for elective caesarean section.Br J Anaesth 1992;68:394–75.Rout CC,Rocke DA,Levin J,Gouws E,Reddy D:A reevaluation of the role of crystalloid preload in the prevention of hypotension asso-ciated with spinal anesthesia for elective cesarean section.A NESTHESI-OLOGY1993;79:262–96.Jackson R,Reid JA,Thorburn J:Volume preloading is not essen-tial to prevent spinal-induced hypotension at Caesarean section.Br J Anaesth1995;75:262–57.Park GE,Hauch MA,Curlin F,Datta S,Bader AM:The effects of varying volumes of crystalloid administration before cesarean delivery on maternal hemodynamics and colloid osmotic pressure.Anesth Analg1996;83:299–3038.Marthru M,Rao TL,Kartha RK,Shanmugham M,Jacobs HK: Intravenous albumin administration for prevention of spinal hypoten-sion during cesarean section.Anesth Analg1980;59:655–89.Baraka AS,Taha SK,Ghabach MB,Sibaii AA,Nader AM:Intravascular administration of polymerized gelatin versus isotonic saline for prevention of spinal-induced hypotension.Anesth Analg1994;78:301–5som I,Forssman L:Factors influencing aortocaval compres-sion in late pregnancy.Am J Obstet Gynecol1984;148:764–7111.Bieniarz J,Crottogini JJ,Curuchet E,Romero-Salinas G,Yoshida T,Poseiro JJ,Caldeyro-Barcia R:Aortocaval compression by the uterus in late human pregnancy.Am J Obstet Gynecol1968;100:203–17 12.Wennberg E,Frid I,Haljamae H,Noren H:Colloid(3%Dextran 70)with or without ephedrine infusion for cardiovascular stability during extradural caesarean section.Br J Anaesth1992;69:13–8 13.He YL,Tanigami H,Ueyama H,Mashimo T,Yoshiya I:Measure-ment of blood volume using indocyanine green measured with pulse-spectrophotometry:Its reproducibility and reliability.Crit Care Med 1998;26:1446–5114.Iijima T,Iwao Y,Sankawa H:Circulating blood volume mea-sured by pulse dye-densitometry:Comparison with(131)I-HSA analy-sis.A NESTHESIOLOGY1998;89:1329–3515.Haruna M,Kumon K,Yahagi N,Watanabe Y,Ishida Y,Koba-yashi N,Aoyagi:Blood volume measurement at the bedside using ICG pulse spectrophotometry.A NESTHESIOLOGY1998;89:1322–816.Aoyagi T,Fuse M,Kanemoto M,Xie CT,Kobayashi N,Hirabara H,Hosaka H,Iijima T,Sankawa H,Haruna M,Tanigami H,Kumon K: Pulse Dye-Densitometry.[in Japanese with English abstract]Jpn J Clin Monitoring1994;5:371–917.Imai T,Takahashi K,Fukura H,Morishita Y:Measurement of cardiac output by pulse dye densitometry using indocyanine green:A comparison with the thermodilution method.A NESTHESIOLOGY1997; 87:816–2218.Robson SC,Hunter S,Boys R,Dunlop W,Bryson M:Changes in cardiac output during epidural anaesthesia for Caesarean section.An-aesthesia1989;44:475–919.Riley ET,Cohen SE,Rubenstein AJ,Flanagan B:Prevention of hypotension after spinal anesthesia for cesarean section:Six percent Hetastarch versus lactated RingerÆs solution.Anesth Analg1995;81: 838–4220.Robson SC,Boys RJ,Rodeck C,Morgan B:Maternal and fetal haemodynamic effects of spinal and extradural anaesthesia for elective caesarean section.Br J Anaesth1992;68:54–921.Ramanathan S,Grant GJ:Vasopressor therapy for hypotension due to epidural anesthesia for Cesarean section.Acta Anaesthesiol Scand1988;32:559–651576UEYAMA ET AL.。

相关文档
最新文档